BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18845622)

  • 21. The globalisation strategies of five Asian tobacco companies: a comparative analysis and implications for global health governance.
    Lee K; Eckhardt J
    Glob Public Health; 2017 Mar; 12(3):367-379. PubMed ID: 28139967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How Philip Morris unlocked the Japanese cigarette market: lessons for global tobacco control.
    Lambert A; Sargent JD; Glantz SA; Ling PM
    Tob Control; 2004 Dec; 13(4):379-87. PubMed ID: 15564622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. British American Tobacco and the "insidious impact of illicit trade" in cigarettes across Africa.
    Legresley E; Lee K; Muggli ME; Patel P; Collin J; Hurt RD
    Tob Control; 2008 Oct; 17(5):339-46. PubMed ID: 18617598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.
    Smith KE; Fooks G; Collin J; Weishaar H; Mandal S; Gilmore AB
    PLoS Med; 2010 Jan; 7(1):e1000202. PubMed ID: 20084098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tobacco control industry strategies in Turkey.
    Keklik S; Gultekin-Karakas D
    BMC Public Health; 2018 Feb; 18(1):282. PubMed ID: 29482539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transnational tobacco company influence on tax policy during privatization of a state monopoly: British American Tobacco and Uzbekistan.
    Gilmore A; Collin J; Townsend J
    Am J Public Health; 2007 Nov; 97(11):2001-9. PubMed ID: 17138915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smuggling as the "key to a combined market": British American Tobacco in Lebanon.
    Nakkash R; Lee K
    Tob Control; 2008 Oct; 17(5):324-31. PubMed ID: 18818226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Turning a threat into an opportunity: British American Tobacco's weakening of the Protocol to Eliminate Illicit Trade in Tobacco Products.
    Gomis B; Gallagher AWA; Rowell A; Gilmore AB
    Tob Control; 2022 Jan; 31(1):40-49. PubMed ID: 34531314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in China.
    Muggli ME; Lee K; Gan Q; Ebbert JO; Hurt RD
    PLoS Med; 2008 Dec; 5(12):1729-69. PubMed ID: 19108603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impacts of the Master Settlement Agreement on the tobacco industry.
    Sloan FA; Mathews CA; Trogdon JG
    Tob Control; 2004 Dec; 13(4):356-61. PubMed ID: 15564618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Political economy of tobacco control in Thailand.
    Chantornvong S; McCargo D
    Tob Control; 2001 Mar; 10(1):48-54. PubMed ID: 11226361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roadmap to a tobacco epidemic: transnational tobacco companies invade Indonesia.
    Hurt RD; Ebbert JO; Achadi A; Croghan IT
    Tob Control; 2012 May; 21(3):306-12. PubMed ID: 21852413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complicity in contraband: British American Tobacco and cigarette smuggling in Asia.
    Collin J; Legresley E; MacKenzie R; Lawrence S; Lee K
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii104-11. PubMed ID: 15564212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the impact of foreign direct investment on tobacco consumption in the former Soviet Union.
    Gilmore AB; McKee M
    Tob Control; 2005 Feb; 14(1):13-21. PubMed ID: 15735295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are transnational tobacco companies' market access strategies linked to economic development models? A case study of South Korea.
    Lee S; Holden C; Lee K
    Glob Public Health; 2013; 8(4):435-48. PubMed ID: 23327486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of British American Tobacco's questionable use of privilege and protected document claims at the Guildford Depository.
    LeGresley E; Lee K
    Tob Control; 2017 May; 26(3):316-322. PubMed ID: 27354678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials.
    Peeters S; Gilmore AB
    PLoS Med; 2013; 10(9):e1001506. PubMed ID: 24058299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the vector in order to plan effective tobacco control policies: an analysis of contemporary tobacco industry materials.
    Gilmore AB
    Tob Control; 2012 Mar; 21(2):119-26. PubMed ID: 22345234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.
    Tong EK; Glantz SA
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii118-24. PubMed ID: 15564214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Through tobacco industry eyes: civil society and the FCTC process from Philip Morris and British American Tobacco's perspectives.
    Gonzalez M; Green LW; Glantz SA
    Tob Control; 2012 Jul; 21(4):e1. PubMed ID: 21636611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.